Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Endocrinology and Metabolism|February 2, 2021
Modified-Release Hydrocortisone in Congenital Adrenal HyperplasiaDeborah P Merke, Ashwini Mallappa, Wiebke Arlt, et al.
Clinical Endocrinology|May 16, 2025
Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease ControlRichard John M Ross, Wiebke Arlt, Aude Brac de la Perriere, et al.
Military Medicine|April 19, 2026
Medic Training at Military-Civilian Partnerships-A Narrative ReviewJohn P Gaspich, Adwik Rahematpura, Angelica L Solomon, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2020
CATS II Long-term Anthropometric and Metabolic Effects of Maternal Sub-optimal Thyroid Function in Offspring and MothersIlaria Muller, Peter N Taylor, Rhian M Daniel, et al.
Current Medical Research and Opinion|November 20, 2015
Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patientsJ Mark Stephens, Larry C Emerson, Leslie A Spry, et al.
Journal of the American Board of Family Medicine : JABFM|January 8, 2017
Primary Care Clinic Re-Design for Prescription Opioid ManagementMichael L Parchman, Michael Von Korff, Laura-Mae Baldwin, et al.
Microbiome|February 17, 2021
Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced diseaseSajad Moshkelgosha, Hedda Luise Verhasselt, Giulia Masetti, et al.
Annals of Family Medicine|July 10, 2019
Team-Based Clinic Redesign of Opioid Medication Management in Primary Care: Effect on Opioid PrescribingMichael L Parchman, Robert B Penfold, Brooke Ike, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2023
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European StudyFilippo Biscarini, Giulia Masetti, Ilaria Muller, et al.
Pageof 19